Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tenax Therapeutics Inc (NASDAQ:TENX)

0.505
Delayed Data
As of May 26
 -0.0023 / -0.45%
Today’s Change
0.41
Today|||52-Week Range
2.78
-74.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$14.3M

Company Description

Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing and commercializing products for the critical care market. Its objective is to identify, develop, and commercialize novel therapeutic products for disease indications that represent significant areas of clinical need and commercial opportunity. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC.

Contact Information

Tenax Therapeutics, Inc.
One Copley Parkway
Morrisville North Carolina 27560
P:(919) 855-2100
Investor Relations:

Employees

Shareholders

Other institutional6.25%
Individual stakeholders5.12%
Mutual fund holders4.52%

Top Executives

Michael B. JebsenPresident, CEO, CFO & Treasurer
Paula BokeschChief Medical Officer
Doug RandallExecutive VP-Business & Commercial Operations
Nancy J. HecoxSecretary, EVP-Legal Affairs & General Counsel
Douglas HayExecutive Vice President-Regulatory Affairs